目前关于糖尿病心血管风险评估的脂质比率的证据:一篇综述
E Carretero-Anibarro1, D Orozco-Beltran2
1Health center José Gallego Arroba, Andalusian Health Service, Spain; University Miguel Hernández of Elche. Department of Clinical Medicine, Alicante, Spain; Primary Care Diabetes Europe Study Group, Belgium; Spanish Society of Family and Community Medicine (Semfyc), Spanish Diabetes Society, Spain; redGDPS Foundation, Spain.
Primary care diabetes
|March 7, 2026
概括
像TG/HDL-C这样的脂质比率可能有助于预测2型糖尿病 (T2DM) 患者的心血管疾病 (CVD). 在对这些新出现的风险标志物进行临床指南认可之前,需要进一步验证.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 代谢综合征是代谢综合征的一种.
背景情况:
- 2型糖尿病 (T2DM) 是心血管疾病 (CVD) 的一个主要风险因素.
- 传统的脂质谱 (TC,LDL-C,HDL-C) 是标准的心血管疾病风险评估工具.
- 新兴的脂质比率显示出在糖尿病人群中改善心血管疾病风险预测的潜力.
研究的目的:
- 审查和批判性地评估用于预测T2DM中心血管疾病风险的脂质比率的证据.
- 评估新型脂质标记物的临床实用性和指南认可.
主要方法:
- 文献审查和对现有研究的批判性评估.
- 专注于脂质比率:TG/HDL-C,TC/HDL-C,非HDL-C/HDL-C,LDL-C/HDL-C,以及TyG指数.
- 对2型糖尿病患者心血管疾病预测价值的分析.
主要成果:
- 脂质比可能为T2DM中心血管疾病提供增量或比较的预测值.
- 临床实用性的证据仍然不足以广泛采用.
- 目前的主要临床指南并不经常支持这些脂质比率.
结论:
- 脂质比为T2DM中心血管疾病风险分层的有希望的生物标志物.
- 需要进一步的强有力的验证研究来确定它们的最终临床作用.
- 未来的研究应该专注于将这些比率纳入临床实践指南.
相关概念视频
Lipids: Dietary Sources and Requirements
2.5K
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
2.5K
Overview of Lipid Metabolism
7.0K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
7.0K
Blood Studies for Cardiovascular System III: Serum Lipid Profile
854
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
854
Coronary Artery Disease I: Introduction
1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease IV: Preventive Measures
890
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741


